bioMérieux - First-Half 2011 Business Review

19 July, 2011

bioMerieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2011.

At constant exchange rates and comparable business base*

First-half sales up 4.3%
Second-quarter sales accelerate: up 5.1%
- Good performance in North America confirmed: up 5.1%
- Strong increase in China: up 35%
Two strategic acquisitions during the period
Confirmation of the 2011 objective for sales growth
Jean-Luc Belingard, Chairman of the Board, takes on the role of CEO, heading the Management Committee, and Stephane Bancel joins Institut Merieux as Senior Advisor

Download the Full Report:

Pioneering Diagnostics